Citation Impact
Citing Papers
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
2015 Standout
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
Aquaporin-4 antibody–negative neuromyelitis optica
2013
Features, Evaluation and Treatment Coronavirus (COVID-19)
2020 Standout
Pathologic heterogeneity persists in early active multiple sclerosis lesions
2014
Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays
2012
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic
2020 Standout
Optical coherence tomography angiography
2017 Standout
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
2011
Control of Regulatory T Cells by Co-signal Molecules
2019 StandoutNobel
Myasthenia Gravis
2016 Standout
Increased serum matrix metalloproteinase-9 in neuromyelitis optica: Implication of disruption of blood–brain barrier
2011
Neuromyelitis Optica
2010
Neurofilament light chain as a biomarker in neurological disorders
2019 Standout
Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk
2020
Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome
2015
Astrocyte barriers to neurotoxic inflammation
2015
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status
2017
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
Anti–Aquaporin‐4 monoclonal antibody blocker therapy for neuromyelitis optica
2011
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
2012
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
2010
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
2012
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Treatment of neuromyelitis optica: Review and recommendations
2012
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Intractable vomiting as the initial presentation of neuromyelitis optica
2010
Prefrontal white matter pathology in air pollution exposed Mexico City young urbanites and their potential impact on neurovascular unit dysfunction and the development of Alzheimer's disease
2016
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
The blood–brain barrier
2016
Sera from neuromyelitis optica patients disrupt the blood–brain barrier
2011
Involvement of glycosphingolipid-enriched lipid rafts in inflammatory responses
2015
The mystery of membrane organization: composition, regulation and roles of lipid rafts
2017 Standout
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
2012
OX40, OX40L and Autoimmunity: a Comprehensive Review
2015
Climate change, environment pollution, COVID-19 pandemic and mental health
2021
Neuromyelitis optica spectrum disorders associated with other autoimmune diseases
2014
Reactive Astrocytes: Production, Function, and Therapeutic Potential
2017 Standout
Aquaporin 4 and neuromyelitis optica
2012
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
2015
Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis
2017
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Maintenance plasma exchange therapy for steroid‐refractory neuromyelitis optica
2012
The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease
2011
Evaluation of aquaporin‐4 antibody assays
2014
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Air Pollution and Children: Neural and Tight Junction Antibodies and Combustion Metals, the Role of Barrier Breakdown and Brain Immunity in Neurodegeneration
2014
The history of neuromyelitis optica
2013
Antibody-Mediated Encephalitis
2018 Standout
The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica
2013
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019
2020
Climate Change 2022 – Impacts, Adaptation and Vulnerability
2023 Standout
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies
2014
Clinical Efficacy of Plasmapheresis in Patients with Neuromyelitis Optica Spectrum Disorder and Effects on Circulating Anti-Aquaporin-4 Antibody Levels
2013
Aquaporin‐4 Antibodies (NMO ‐IgG ) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature
2013
Interferons in the central nervous system: A few instruments play many tunes
2013
Model of Aquaporin-4 Supramolecular Assembly in Orthogonal Arrays Based on Heterotetrameric Association of M1-M23 Isoforms
2011
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions
2013
Multiple Sclerosis
2018 Standout
Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder
2009
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
2014
Aquaporin-4 antibody–positive cases beyond current diagnostic criteria for NMO spectrum disorders
2013
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Autonomic Dysregulation, Cognitive Impairment, and Symptoms of Psychosis as an Unusual Presentation in an Anti-Aquaporin 4-Positive Patient.
2017 Standout
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
2012
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Magnetite pollution nanoparticles in the human brain
2016 Standout
Serologic diagnosis of NMO
2012
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants
2015
Plasma Exchange in Severe Attacks of Neuromyelitis Optica
2012
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
2011
NMDA receptor antibodies associated with distinct white matter syndromes
2014
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
2013
Induction of Memory Deficit in Mice with Chronic Exposure to Cerebrospinal Fluid from Patients with Anti-<i>N</i>-Methyl-D-Aspartate Receptor Encephalitis
2015
Mechanisms of white matter damage in multiple sclerosis
2014
Works of Simone Mader being referenced
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
2011
Pathogenic T cell responses against aquaporin 4
2011
Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats
2013
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
2009
Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
2010
Anti–Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Patients With Optic Neuritis
2012
T cell-activation in neuromyelitis optica lesions plays a role in their formation
2013
Systemic Inflammation and the Brain: Novel Roles of Genetic, Molecular, and Environmental Cues as Drivers of Neurodegeneration
2015
Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice
2016
Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases
2010
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases
2013
Brain-Reactive Antibodies and Disease
2013
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders
2011
Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica
2012